ChemoCentryx Inc. (CCXI)

7.58
NASDAQ : Health Technology
Prev Close 7.64
Day Low/High 7.32 / 7.85
52 Wk Low/High 6.16 / 14.98
Avg Volume 436.10K
Exchange NASDAQ
Shares Outstanding 58.25M
Market Cap 445.03M
EPS -0.80
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

ChemoCentryx Reports Second Quarter 2019 Financial Results And Recent Highlights

ChemoCentryx Reports Second Quarter 2019 Financial Results And Recent Highlights

-- Topline data from pivotal ADVOCATE Phase III trial of C5a receptor inhibitor avacopan in ANCA Vasculitis on track for Q4 2019 -- -- Completed enrollment in LUMINA 1 Phase II trial of CCR2 inhibitor CCX140 in Focal Segmental Glomerulosclerosis (FSGS) --...

ChemoCentryx To Hold Second Quarter 2019 Financial Results Conference Call On Monday, August 5, 2019

ChemoCentryx To Hold Second Quarter 2019 Financial Results Conference Call On Monday, August 5, 2019

MOUNTAIN VIEW, Calif., July 31, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc.

Oversold Conditions For ChemoCentryx (CCXI)

Oversold Conditions For ChemoCentryx (CCXI)

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Notable Thursday Option Activity: CCXI, SEAS, AMN

Notable Thursday Option Activity: CCXI, SEAS, AMN

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in ChemoCentryx, Inc. , where a total of 3,419 contracts have traded so far, representing approximately 341,900 underlying shares.

ChemoCentryx Breaks Above 200-Day Moving Average - Bullish For CCXI

ChemoCentryx Breaks Above 200-Day Moving Average - Bullish For CCXI

In trading on Tuesday, shares of ChemoCentryx, Inc. crossed above their 200 day moving average of $11.43, changing hands as high as $11.66 per share.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: NBLX, NOK, OSPN, PATK, PUMP Downgrades: AMPH, CCXI, CXO, FUN, OTIV Initiations: WSC Read on to get TheStreet Quant Ratings' detailed report:

ChemoCentryx (CCXI) Shares Cross Below 200 DMA

ChemoCentryx (CCXI) Shares Cross Below 200 DMA

In trading on Tuesday, shares of ChemoCentryx, Inc. crossed below their 200 day moving average of $11.53, changing hands as low as $11.35 per share.

Interesting CCXI Put And Call Options For May 17th

Interesting CCXI Put And Call Options For May 17th

Investors in ChemoCentryx, Inc. saw new options become available this week, for the May 17th expiration.

CCXI Makes Bullish Cross Above Critical Moving Average

CCXI Makes Bullish Cross Above Critical Moving Average

In trading on Friday, shares of ChemoCentryx, Inc. crossed above their 200 day moving average of $11.62, changing hands as high as $11.80 per share.

CCXI Makes Notable Cross Below Critical Moving Average

CCXI Makes Notable Cross Below Critical Moving Average

In trading on Monday, shares of ChemoCentryx, Inc. crossed below their 200 day moving average of $10.82, changing hands as low as $10.63 per share.

Don't Fade Monday Market Strength

Don't Fade Monday Market Strength

It may be tempting to try, but fading strong Monday's hasn't been a good strategy lately.

4 Small Speculative Names on My Radar

4 Small Speculative Names on My Radar

While I'm waiting for some index excitement I'm focused on trades in individual stocks.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: ANGO, CCXI, EGN, ETSY, MRVL, PAY, PRTY, WAIR Downgrades: NGS, RES, SYKE, URG Initiations: NODK, SLD Read on to get TheStreet Quant Ratings' detailed report:

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-Cap Stocks Are Doing Something They Haven't Done Consistently in 3 Years

Small-cap stocks have finally jumped back to life on prospects for a strong U.S. economy this year. What trade war?

There's Only One Way to Effectively Trade This Crazy Stock Market

There's Only One Way to Effectively Trade This Crazy Stock Market

Forget resistance levels, oversold readings and everything else.

Commit To Purchase ChemoCentryx At $5, Earn 24.3% Annualized Using Options

Commit To Purchase ChemoCentryx At $5, Earn 24.3% Annualized Using Options

Investors eyeing a purchase of ChemoCentryx, Inc. shares, but cautious about paying the going market price of $8.45/share, might benefit from considering selling puts among the alternative strategies at their disposal.

TheStreet Quant Rating: D (Sell)